Similar articles

• [The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension].

  Lydtin H. Lydtin H. Med Welt. 1975 Aug 29;6(35):1487-92. Med Welt. 1975. PMID: 240998 German. No abstract available.
• [Principal pharmacological properties of different beta-blockers, possibilities and new perspectives of their uses].

  Antelava N, Antelava A, Pachkoria K, Pirtskhalaishvili N. Antelava N, et al. Georgian Med News. 2006 Dec;(141):38-46. Georgian Med News. 2006. PMID: 17261885 Review. Russian.
• [Beta blockers in the treatment of arterial hypertension].

  Spinar J, Vítovec J. Spinar J, et al. Cas Lek Cesk. 1998 May 4;137(9):278-81. Cas Lek Cesk. 1998. PMID: 9650357 Review. Czech.
• [Beta-adrenergic receptor blockers in clinical practice].

  Czuriga I, Edes I. Czuriga I, et al. Orv Hetil. 2004 Sep 19;145(38):1951-60. Orv Hetil. 2004. PMID: 15535106 Review. Hungarian.
• Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular events.

  Fragasso G, Cera M, Margonato A. Fragasso G, et al. J Am Coll Cardiol. 2009 Jun 2;53(22):2105; author reply 2106-7. doi: 10.1016/j.jacc.2008.12.075. J Am Coll Cardiol. 2009. PMID: 19477370 No abstract available.